Reuters logo
4 years ago
China's Shandong Weigao to sell entire stake in Biosensors for $312.3 million
November 22, 2013 / 1:10 AM / 4 years ago

China's Shandong Weigao to sell entire stake in Biosensors for $312.3 million

A lab technician in Singapore performs quality control checks on a biodegradable stent, which is inserted into constricted coronary arteries to help keep them open and normalise blood flow during the treatment heart ailments, September 18, 2008.Vivek Prakash

HONG KONG (Reuters) - Shandong Weigao Group Medical Polymer Co Ltd (1066.HK) said on Friday it would sell its entire 21.7 percent stake in medical device maker Biosensors International Group Ltd BIOS.SI for $312.3 million to focus on its main businesses.

The Hong Kong-listed medical device maker will sell the Biosensors stake to CB Medical Holdings Ltd at S$1.05 per share, representing an 11.7 percent premium over Biosensors' previous close, Shandong Weigao said in a filing to the Hong Kong bourse.

Shangdong Weigao said it estimated 449 million yuan ($73.69 million) loss from the disposal, while the proceed would be used to strengthen its principal businesses in medical consumables, blood purification and orthopedic products.

Shares in Biosensors rose 1.6 percent to S$0.95.

($1 = 6.0932 Chinese yuan)

Reporting by Donny Kwok; Editing by Anand Basu

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below